TVTX logo

Travere Therapeutics, Inc. (TVTX) Debt To Equity Ratio

Annual Debt To Equity:

6.80+4.78(+236.63%)
December 31, 2024

Summary

  • As of today, TVTX annual debt to equity ratio is 6.80, with the most recent change of +4.78 (+236.63%) on December 31, 2024.
  • During the last 3 years, TVTX annual debt to equity has risen by +5.93 (+681.61%).
  • TVTX annual debt to equity is now -28.50% below its all-time high of 9.51, reached on December 31, 2022.

Performance

TVTX Debt To Equity Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTVTXfinancial health metrics

Quarterly Debt To Equity:

12.200.00(0.00%)
June 30, 2025

Summary

  • As of today, TVTX quarterly debt to equity ratio is 12.20, unchanged on June 30, 2025.
  • Over the past year, TVTX quarterly debt to equity has dropped by -14.42 (-54.17%).
  • TVTX quarterly debt to equity is now -84.28% below its all-time high of 77.63, reached on June 30, 2014.

Performance

TVTX Quarterly Debt To Equity Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTVTXfinancial health metrics

Debt To Equity Formula

Debt To Equity =  
Total Debt
Shareholders Equity

TVTX Debt To Equity Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1Y1 Year+236.6%-54.2%
3Y3 Years+681.6%+369.2%
5Y5 Years+601.0%+1668.1%

TVTX Debt To Equity Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs Low
3Y3-Year-28.5%+681.6%-54.2%+192.3%
5Y5-Year-28.5%+681.6%-54.2%+192.3%
All-TimeAll-Time-28.5%+402.2%-84.3%+192.3%

TVTX Debt To Equity History

DateAnnualQuarterly
Jun 2025
-
12.20(0.0%)
Mar 2025
-
12.20(+79.4%)
Dec 2024
6.80(+236.6%)
6.80(+151.5%)
Sep 2024
-
-13.21(-149.6%)
Jun 2024
-
26.62(+388.4%)
Mar 2024
-
5.45(+169.8%)
Dec 2023
2.02(-78.8%)
2.02(+39.3%)
Sep 2023
-
1.45(-58.5%)
Jun 2023
-
3.49(+62.3%)
Mar 2023
-
2.15(-77.4%)
Dec 2022
9.51(+993.1%)
9.51(+134.8%)
Sep 2022
-
4.05(+55.8%)
Jun 2022
-
2.60(+32.7%)
Mar 2022
-
1.96(+125.3%)
Dec 2021
0.87(-25.0%)
0.87(+2.4%)
Sep 2021
-
0.85(+10.4%)
Jun 2021
-
0.77(+11.6%)
Mar 2021
-
0.69(-40.5%)
Dec 2020
1.16(+19.6%)
1.16(+45.0%)
Sep 2020
-
0.80(+15.9%)
Jun 2020
-
0.69(-25.8%)
Mar 2020
-
0.93(-4.1%)
Dec 2019
0.97(+42.6%)
0.97(+11.5%)
Sep 2019
-
0.87(+14.5%)
Jun 2019
-
0.76(-6.2%)
Mar 2019
-
0.81(+19.1%)
Dec 2018
0.68(+353.3%)
0.68(+1.5%)
Sep 2018
-
0.67(+318.8%)
Jun 2018
-
0.16(+6.7%)
Mar 2018
-
0.15(0.0%)
Dec 2017
0.15
0.15(0.0%)
Sep 2017
-
0.15(0.0%)
Jun 2017
-
0.15(0.0%)
DateAnnualQuarterly
Mar 2017
-
0.15(+7.1%)
Dec 2016
0.14(-6.7%)
0.14(0.0%)
Sep 2016
-
0.14(0.0%)
Jun 2016
-
0.14(0.0%)
Mar 2016
-
0.14(-6.7%)
Dec 2015
0.15(+106.7%)
0.15(0.0%)
Sep 2015
-
0.15(-73.2%)
Jun 2015
-
0.56(+12.0%)
Mar 2015
-
0.50(+122.2%)
Dec 2014
-2.25(>-9900.0%)
-2.25(+72.5%)
Sep 2014
-
-8.18(-110.5%)
Jun 2014
-
77.63(+8921.6%)
Mar 2014
-
-0.88(>-9900.0%)
Dec 2013
0.00(+100.0%)
0.00(0.0%)
Sep 2013
-
0.00(0.0%)
Jun 2013
-
0.00(0.0%)
Mar 2013
-
0.00(+100.0%)
Dec 2012
-0.26(+36.6%)
-0.26(+35.0%)
Nov 2011
-
-0.40(+2.4%)
Aug 2011
-
-0.41(0.0%)
May 2011
-
-0.41(0.0%)
Feb 2011
-0.41(-20.6%)
-0.41(+2.4%)
Nov 2010
-
-0.42(-2.4%)
Aug 2010
-
-0.41(-10.8%)
May 2010
-
-0.37(-8.8%)
Feb 2010
-0.34(-161.5%)
-0.34(-13.3%)
Nov 2009
-
-0.30(-20.0%)
Aug 2009
-
-0.25(-31.6%)
May 2009
-
-0.19(-46.2%)
Feb 2009
-0.13(>-9900.0%)
-0.13(-333.3%)
Nov 2008
-
-0.03(+93.8%)
Aug 2008
-
-0.48(0.0%)
May 2008
-
-0.48
Feb 2008
0.00
-

FAQ

  • What is Travere Therapeutics, Inc. annual debt to equity ratio?
  • What is the all-time high annual debt to equity for Travere Therapeutics, Inc.?
  • What is Travere Therapeutics, Inc. annual debt to equity year-on-year change?
  • What is Travere Therapeutics, Inc. quarterly debt to equity ratio?
  • What is the all-time high quarterly debt to equity for Travere Therapeutics, Inc.?
  • What is Travere Therapeutics, Inc. quarterly debt to equity year-on-year change?

What is Travere Therapeutics, Inc. annual debt to equity ratio?

The current annual debt to equity of TVTX is 6.80

What is the all-time high annual debt to equity for Travere Therapeutics, Inc.?

Travere Therapeutics, Inc. all-time high annual debt to equity ratio is 9.51

What is Travere Therapeutics, Inc. annual debt to equity year-on-year change?

Over the past year, TVTX annual debt to equity ratio has changed by +4.78 (+236.63%)

What is Travere Therapeutics, Inc. quarterly debt to equity ratio?

The current quarterly debt to equity of TVTX is 12.20

What is the all-time high quarterly debt to equity for Travere Therapeutics, Inc.?

Travere Therapeutics, Inc. all-time high quarterly debt to equity ratio is 77.63

What is Travere Therapeutics, Inc. quarterly debt to equity year-on-year change?

Over the past year, TVTX quarterly debt to equity ratio has changed by -14.42 (-54.17%)
On this page